Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2022

View Archived Issues

[68Ga]DOTA-ECL1i PET imaging in pancreatic cancer metastasis

KLF5 as novel therapeutic target to reduce tumorigenic GBM phenotype

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

Carbon Biosciences raises series A financing to advance cystic fibrosis program toward clinic

COR-803 reduces SARS-CoV-2 viral load in vivo after oral treatment

FOXI3 gene tied to craniofacial microsomia

NLRP11 identified as an essential component of the NLRP3 inflammasome in human macrophages

Study rekindles hope for exercise pill -- or at least, molecular exercise science

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...